ACRS holders · CITADEL ADVISORS LLC 13F · ACRS stock
CITADEL ADVISORS LLC Aclaris Therapeutics Inc (ACRS) 13F holding
CITADEL ADVISORS LLC reported 1,824,176 ACRS shares valued at $6.84B as of 2026-03-31 (COM). Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 1,824,176 | $6.84B | COM |
| 2026-03-31 | 466,400 | $1.75B | Call |
| 2026-03-31 | 425,143 | $1.59B | COM |
| 2026-03-31 | 102,300 | $383.6M | Put |
| 2025-12-31 | 1,138,400 | $3.43B | Call |
| 2025-12-31 | 624,141 | $1.88B | COM |
| 2025-12-31 | 581,140 | $1.75B | COM |
| 2025-09-30 | 1,166,729 | $2.22B | COM |
| 2025-09-30 | 265,948 | $505.3M | COM |
| 2025-06-30 | 686,196 | $974.4M | COM |
| 2025-06-30 | 457,610 | $649.8M | COM |
Not investment advice. Cached 13F row, not EDGAR XML.